Biogen’s great earnings could spur more inflated biotech stock prices

If second quarter earnings reported tonight by Gilead, and tomorrow morning by Celgene, are as good as what we saw from Biogen Idec this morning, you can bank on a reinflation of the biotech bubble for the next several months to come...